×

To enhance security, Multi-Factor Authentication (MFA) is mandatory for all HL7 users. More information

 

FHIR Implementation Guide for Transfusion and Vaccination Adverse Event Reporting (PSS in Confluence)

Basics

FHIR Implementation Guide for Transfusion and Vaccination Adverse Event Reporting (PSS in Confluence)

1644
Ballot - STU to Normative


FHIR Implementation Guide

Implementation Guide

Details

The FHIR Implementation Guide provides a set of profiles for detection, validation, reporting, and ultimately recording/persisting Adverse Events associated with blood transfusions and vaccinations. There are two sets of profiles with the first set intended to enable the detection, validation, and recording of conditions and observations on a patient’s record that would indicate the occurrence of an Adverse Event. The second set of profiles provides mappings to the ICH Individual Care Study Report (ICSR) specifications, specifically FDA’s FAERS (FDA Adverse Event Reporting System) and VAERS (Vaccine Adverse Event Reporting System) implementations of those specifications, for the purposes of allowing the submission of Adverse Event Case Reports to FDA using the FHIR profiles after they have been transformed into the current XML specifications.

This FHIR implementation guide will use the US Core profiles. If this FHIR implementation guide is unable to use a US Core profile, we will request approval from the US Realm Steering Committee, and provide the US Realm Steering Committee an approved rationale for deviation in the implementation guide where applicable.


Vendor implementations of FHIR servers, along with the US Core Profiles, lack many of the granular data elements needed for detection and reporting of adverse events related to biologic products. Due to this limitation, provider networks often resort to manual creation of these reports and have not widely pursued electronic submission of adverse event reports to regulatory agencies like the FDA. To facilitate electronic reporting of adverse events, and interoperability of data for patients experiencing these events, this implementation guide gives guidance on the data elements needed for detection, validation, and reporting of biologics-related adverse events. This includes data elements needed to capture the granular details of exposure to the suspect drug/biologic, along with documenting the adverse event/outcome associated with the suspect drug/biologic.



Development of Implementation Guide ready for Connectathon - Target: 2021 January Testing at HL7 FHIR Connectathon - Target: 2021 January FHIR Connectathon Ready for First STU Ballot - Target: 2021 May Ballot Complete STU Reconcilation - Target: 2021 June STU Publication - Target: 2021 July STU Period - Target: 2021 July - 2022 July Normative Ballot - Target: 2022 September Ballot Complete Normative Ballot Reconciliation - Target: 2022 October Normative Publication - Target: 2022 November Project End Date (all objectives have been met) - Target: 2022 November 27


https://confluence.hl7.org/display/BRR/FHIR+Implementation+Guide+for+Transfusion+and+Vaccination+Adverse+Event+Reporting

Was the content externally developed ? : Y IBM BEST C2 Project (Jean Duteau)


Regulatory Agency,Healthcare Institutions (hospitals, long term care, home care, mental health),Pharmaceutical; EHR, PHR

1) IBM BEST C2 Project 2) MedStar




Yes

N/A

No

2022 January: TSC approved STU Publication request for HL7 FHIR Implementation Guide: Profiles for ICSR Transfusion and Vaccination Adverse Event Detection and Reporting, STU 1 for 2 years.
Organization & Realm

Realm Specific - Enter "U.S." or name of HL7 Affiliate below

U.S.
People

Jean Duteau



Biomedical Research and Regulation Work Group

Patient Care Work Group; Public Health Work Group

Status & Dates

Active

STU - Reconcile

07/21/2020

01/15/2028

2028 Jan WGM/Ballot

01/15/2027

2027 Jan WGM/Ballot

2021 Sept Ballot Cycle Info: STU Ballot results: Met basic vote requirements. 4 Negatives to reconcile Document Name: HL7 FHIR Implementation Guide: Transfusion and Vaccination Adverse Event Reporting, Release 1 - US Realm (See Jira Ballot Dashboard)
Approvals

08/31/2020


Received


All Received




System Info






09/17/2026

Anne Wizauer